Plus Therapeutics, Inc. | CYTX - Current Liabilities

Cytori Therapeutics reported $11.85M in Current Liabilities for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Liabilities Change
Baxter International BAX:US USD 4.74B 1.04B
Cerus CERS:US USD 117.06M 22.04M
Cytori Therapeutics CYTX:US USD 11.85M 4.43M
Haemonetics HAE:US USD 226.89M 35.29M
Infinity Pharmaceuticals INFI:US USD 14.2M 139K
Merrimack Pharmaceuticals MACK:US USD 448K 7K
Mirati Therapeutics MRTX:US USD 159.45M 32.46M
Northwest Biotherapeutics NWBO:US USD 116.13M 17.97M
Starpharma Holdings Ltd SPL:AU AUD 10.23M 941K
Teva Pharmaceutical TEVA:IT USD 11.47B 65M